Perrigo Generic Claritin Could Launch End Of Fiscal 2003 – CEO Gibbons
This article was originally published in The Tan Sheet
Executive Summary
Perrigo is considering partnering with an Rx generic drug firm to market a private label version of Schering-Plough's Claritin, should the product switch over-the-counter
You may also be interested in...
Perrigo Loses Acetaminophen Supplier, Gains Loratadine Deal
The loss of a supplier could cost Perrigo up to $18 mil. in acetaminophen product sales in fiscal year 2004, the private labeler said
Perrigo Loses Acetaminophen Supplier, Gains Loratadine Deal
The loss of a supplier could cost Perrigo up to $18 mil. in acetaminophen product sales in fiscal year 2004, the private labeler said
Perrigo Loses Acetaminophen Supplier, Gains Loratadine Deal
The loss of a supplier could cost Perrigo up to $18 mil. in acetaminophen product sales in fiscal year 2004, the private labeler said